Studiomaca Corporation maintains the Studiomaca Web site as a service to the Internet community. The Studiomaca Corporation Web site has been designed to provide general information about Studiomaca and its products. These pages are not intended to provide investment or medical advice, nor do they provide instruction on the appropriate use of products produced, supplied or under development by Studiomaca Corporation, its affiliates, related companies, or its licensors or joint venture partners. Access and use of the Studiomaca Web site is subject to the terms and conditions set forth herein and all applicable laws, statutes, and/or regulations.
Studiomaca Corporation may revise these terms and conditions from time to time by updating this posting. Studiomaca Corporation will use reasonable efforts to include accurate and up-to-date information on the Studiomaca web site, but Studiomaca Corporation makes no warranties or representations as to the accuracy of information presented on the Studiomaca web site. Studiomaca shall not be held responsible for any action taken that is based on the information presented on the Studiomaca Web site, and all users of the Studiomaca Web site agree that all access and use of the Studiomaca Web site, and any and all content presented on the Studiomaca Web site, is at the user's own risk. Neither Studiomaca Corporation nor any party involved in creating, producing or delivering this site shall be liable for any direct, incidental, consequential, indirect, or punitive damages arising out of user's access, use, or inability to use the Studiomaca Web site, or any errors or omissions in the content of the Studiomaca Web site. Any communication or material you transmit to Studiomaca Corporation via the Studiomaca Web site or Internet electronic mail may be accessed and viewed by other Internet users, without your knowledge and permission, while in transit to Studiomaca. For that reason, do not use email to communicate information to us that you consider confidential. Whenever you submit information via this site, you consent to the collection, use, and disclosure of that information in accordance with Studiomaca Corporation's Privacy Statement.
It is the policy of Studiomaca Corporation to enforce its intellectual property rights to the fullest extent permitted under law. All product names, regardless of whether or not they appear in large print or with a trademark symbol, are trademarks of Studiomaca Corporation, its affiliates, related companies, or its licensors or joint venture partners, unless otherwise noted. The entire content of the Studiomaca Corporation Web site, including any images or text, is copyrighted and may not be distributed, downloaded, modified, reused, reposted, or otherwise used except as provided herein without the express written permission of Studiomaca Corporation. The use or misuse of these trademarks, copyrights, or other materials, except as permitted herein, is expressly prohibited and may be in violation of copyright law, trademark law, communications regulations and statutes, and other laws, statutes and/or regulations.
Except for the historical information contained herein, the matters discussed on this Web site may constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 that involves risks and uncertainties that could cause actual results to differ materially from those projected. These statements may be identified by their use of forward-looking terminology such as “believes,” “expects,” “anticipates,” “may,” “will,” “should,” “seeks,” “approximates,” “intends,” “plans,” “estimates” or the negative of these words or other comparable terminology. The most significant of these risks and uncertainties are described in the Company's Form 10-K, Form 10-Q and Form 8-K reports filed with the Securities and Exchange Commission and include, but are not limited to: the resolution or outcome of pending litigation and government investigations relating to the Company's previously announced financial restatement (“Restatement”); the effect of the events relating to, or arising out of, the Restatement on the Company's ability to attract and retain employees and management; the changing U.S. healthcare environment, including potential changes in private and governmental reimbursement for healthcare products and services, the method by which such products and services are delivered, legislation or regulations governing such products and services, or mandated benefits or changes in manufacturer's pricing or distribution policies; substantial defaults in payment or a material reduction in purchases by large customers; the ability of Studiomaca Information Solutions to retain existing customers and to attract new customers in light of rapid technological advances, challenges in integrating the Company's software products, or the slowing or deferral of demand for such products resulting from the impact of current or pending government regulations; the timing and amounts of the ongoing customer settlement process; and the Company's ability to successfully integrate and operate acquired businesses, and manage the risks associated with such businesses, including the acquisition that created Studiomaca HBOC, Inc. The Company assumes no obligation to update information contained in this Web site.